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Development of a Novel Ex-vivo 
3D Model to Screen Amoebicidal 
Activity on Infected Tissue
Nancy Elena Guzmán-Delgado1, Irma Edith Carranza-Torres2,3, Sara García-Davis3, 
Gildardo Rivera4, Javier Morán-Martínez5, Nadia Denys Betancourt-Martínez5, 
G. M. M. Groothuis6, I. A. M. de Graaf6 & Pilar Carranza-Rosales  2
Amoebiasis is a parasitic disease that causes thousands of deaths every year, its adverse effects and 
resistance to conventional treatments have led to the search of new treatment options, as well as 
the development of novel screening methods. In this work, we implemented a 3D model of intestine 
and liver slices from hamsters that were infected ex vivo with virulent E. histolytica trophozoites. 
Results show preserved histology in both uninfected tissues as well as ulcerations, destruction of the 
epithelial cells, and inflammatory reaction in intestine slices and formation of micro abscesses, and 
the presence of amoebae in the sinusoidal spaces and in the interior of central veins in liver slices. The 
three chemically synthetized compounds T-001, T-011, and T-016, which act as amoebicides in vitro, 
were active in both infected tissues, as they decreased the number of trophozoites, and provoked 
death by disintegration of the amoeba, similar to metronidazole. However, compound T-011 induced 
signs of cytotoxicity to liver slices. Our results suggest that ex vivo cultures of precision-cut intestinal 
and liver slices represent a reliable 3D approach to evaluate novel amoebicidal compounds, and to 
simultaneously detect their toxicity, while reducing the number of experimental animals commonly 
required by other model systems.
The intestinal parasite Entamoeba histolytica (E. histolytica) is the causative agent of amoebiasis. This disease is 
the fourth cause of death produced by protozoan parasites1. According to the World Health Organization, E. his-
tolytica infects approximately 500 million people worldwide. However, because of the intra hospital variability in 
incubation period and disease presentation, only 10–20% of E. histolytica infections lead to 50 million reported 
cases of invasive disease and mortality in 100,000 persons each year2,3. In some cases, trophozoites destroy the 
intestinal mucosa and spread to other organs through the bloodstream producing extra-intestinal infections, the 
most common of which is amoebic liver abscess4,5.
For the treatment of intestinal and extra-intestinal amoebiasis, 5-nitroimidazole derivatives such as metroni-
dazole, remain as the first therapeutic option6. However, this class of drugs produces undesirable side effects such 
as nausea, vomiting, diarrhea, hypersensitivity, and may even induce carcinogenesis7,8. Since the introduction 
of metronidazole for the treatment of amoebiasis, few other treatments have been developed. Nevertheless, this 
disease is still responsible for a high morbidity and mortality rates worldwide, mainly due to the increase in resist-
ance to these and other anti-amoebic drugs8–10.
On the other hand, in recent years the interest in designing and synthetizing new antiparasitic molecules has 
been renewed, facilitated by the application of in silico docking; by using such techniques several research groups 
have investigated newly synthetized molecules as potential antiprotozoal compounds, reporting active molecules 
against E. histolytica and other protozoa11,12. An example of these bioactive compounds are T-001, T-011, and 
T-016 (Table 1), which are quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives11, and were used in the present 
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work to validate the model reported here. Although the aforementioned compounds possess in vitro activity 
against E. histolytica, tissue-acting drugs are required to treat invasive amoebiasis, which usually are evaluated 
in either in vitro and/or in vivo models. Although in vivo models have contributed significantly to the study of 
amoebiasis, there is no animal model that mimics the whole cycle of the human disease13. For most in vitro stud-
ies, axenic cultures of E. histolytica are used14,15. However, it has been reported that long-term axenic cultivation 
has a profound effect on E. histolytica virulence and several virulence markers, and culture conditions induce a 
strong selective pressure on E. histolytica, since amoebic virulence can vary from zero to its highest grade, or vice 
versa16. Also, in vitro cultures lack complex interactions between stroma components and different cell types that 
contribute to amoeba pathogenesis in animals. Regarding the latter, ex vivo cultures of precision-cut intestinal 
and hepatic slices represent alternative 3D models that contain all of the cell types belonging to the tissue from 
which they were obtained, and are therefore considered as mini-organs. Slices have many advantages over in vitro 
and in vivo systems, i.e. they retain their metabolic and transport capacity among others17. In previous papers, our 
group reported that hamster liver slices infected with E. histolytica represent an ex vivo 3D model to study hepatic 
amoebiasis based on morphological and molecular characterization of the disease ex vivo18,19. In these studies, we 
observed that morphologic characteristics in amoebae were conserved at the evaluated experimental times, as were 
eritophagocytic activity, immune response reaction, and virulence factors induction. Furthermore, Bansal et al.20  
reported human colon explants to analyze amoebic virulence factors and reproduce the intestinal invasion by E. 
histolytica as well as the tissue non-response to E. dispar, a non-pathogenic species. Similarly, Girard-Misguich 
et al.21 utilized porcine colonic explants, derived from miniature histocompatible SLAd/d piglets, to co-culture 
with virulent (HM1:IMSS) and avirulent (Rahman) strains of E. histolytica. They were able to observe the tissue 
invasion by the trophozoites and the typical innate immune response, similarly to the report on human colon 
explants. Likewise, Ximenez et al.22 evaluated genes related to the pathogenicity and E. histolytica survival, and 
genes linked to the immune response in precision cut liver slices from human tissue. The afore mentioned studies 
and the present work differ between them in the origin of the tissue employed (hamster, pig or human), explant 
preparation methodology (manual or semiautomatic), culture media, amoeba strains (virulent/avirulent), tro-
phozoite inocula, and evaluated genes (host or parasite genes).
In spite of the technical differences, tissue explants have been successfully used to reproduce the infections 
with E. histolytica20–22 and have the advantage to apply one of the principles of the 3 R’s philosophy, reducing the 
number of animals for experimentation.
With the acquired experience using liver slices as 3D cultures, in the present work we implemented the ex 
vivo culture of intestinal slices as an infection model of E. histolytica. Moreover infected precision-cut hamster 
liver and intestinal slices were used to analyze anti-amoebic activity, and at the same time, the possible toxicity of 
the amoebicidal molecules T-001, T-011, and T-016 in the infected tissue, in comparison to metronidazole as a 
reference compound.
This experimental approach allowed us to investigate effectivity of the tested compounds against E. histolytica 
in tissue, and demonstrates the feasibility of the model for the research of new antiprotozoal drugs.
Results
Amoebicidal and cytotoxic effect of T-001, T-011, and T-016. All three compounds, T-001, T-011, 
and T-016 were effective against E. histolytica, with IC50 values < 2 µM. Compound T-011 was cytotoxic in vitro 
against Vero cell cultures (IC50 = 5.86 µM), whereas T-001 and T-016 were not cytotoxic (IC50 > 100 µM), result-
ing in selectivity index (SI) > 65; these two compounds have anti-amoebic activity and SI higher than the refer-
ence drug metronidazole (IC50 = 4.5 and a SI > 22.22). These results are summarized in Table 1.
Compound* Chemical Structure
IC50 vs E. 
histolytica
IC50 vs Vero 
Cells SI
T-001 1.41 >100 >70.92
T-011 0.35 5.86 16.74
T-016 1.47 >100 >68.02
Mtz 4.50 >100 >22.22
Table 1. Amoebicidal activity and cytotoxicity of the synthetic compounds. *Duque-Montaño et al., 2013. IC50 
in µM. Mtz: Metronidazole.
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Obtaining precision-cut hamster intestinal slices. The preparation and culture of complete tissue 
slices from hamster intestine and liver was successfully established using the Krumdieck tissue slicer (Fig. 1). 
The slices prepared in this way maintained histological and morphologic characteristics of the normal intestine, 
preserved intestinal microvilli (Fig. 2a), and remained viable during the incubation period (Fig. 2b–e).
Infection of precision-cut hamster intestinal slices with E. histolytica. Experimental infection of 
the intestinal slices was also achieved successfully. Figure 3 shows ulcerations in the mucosa of the colon due 
to infection with the trophozoites of E. histolytica. Amoebae were frequently observed in close contact with the 
epithelial cells and subsequently penetrated the mucosa in a massive way, inducing a marked acute inflammatory 
response characterized by the presence of polymorphonuclear cells and eosinophils. All of these morphological 
events related to the experimental infection were observed indistinctly at 3 h (Fig. 3a,b), 6 h (Fig. 3c,d) and 9 h 
(Fig. 3e,f). It is important to mention that under our experimental conditions, amoebae remained viable and 
healthy during the infection assays, as judged by their invasive ability, pseudopodia formation and change of 
shape inside the stromal tissue, as well as elevated erythrophagic activity, and the induction of characteristic tissue 
lesions observed in intestinal amoebiasis.
Amoebicide effect of T-001, T-011, and T-016. As we expected, the synthetic compounds showed ex vivo 
amoebicide effect in both, intestine (Fig. 4), and liver (Fig. 5) slices infected with the virulent trophozoites of 
E. histolytica, and their amoebicidal effect was comparable to metronidazole. In both tissues, the compounds 
induced a marked decrease in the number of trophozoites, and fragmentation/disintegration of the amoebae.
With regard to the anti-amoebic effect in intestinal slices, representative images of control and infected slices 
cultured during 9 h in presence or absence of compounds are shown in Fig. 4. In the slices cultured only with 
culture medium (negative control) the histologic structure is well preserved, (Fig. 4a); meanwhile in the infected 
slices, numerous viable amoebae at the intraluminal level, severe acute inflammation, ulceration of the intestinal 
mucosa, and intracryptic abscesses were frequently observed (Fig. 4b). As expected, the pharmacological control 
(metronidazole) induced death of the amoebae and therefore decreased their number (Fig. 4c), with this treat-
ment a “dirty background” due to cell debris derived from inflammatory cells was usually present. In the intestinal 
slices infected and incubated with the synthetic compounds (Fig. 4d–f), a decrease in number of amoebae per 
field was also observed, in a similar way to metronidazole. In the infected slices incubated in the presence of the 
synthetic compounds, amoebae in disintegration process were observed, but in less extension than metronida-
zole. Compared to compounds T-001 and T-016, T-011 showed greater amoebicidal effect on the infected tissue.
In liver slices infected with E. histolytica trophozoites and treated with the synthetic compounds T-001, T-011 
and T-016 (Fig. 5d–f, respectively), a marked decrease in number of amoebae per microscopic field and frag-
mented amoebae, as well as acute inflammatory response cells were frequently seen. The anti-amoebic effect was 
similar to metronidazole (Fig. 5c). When non-infected slices were incubated in presence of the synthetic com-
pounds, T-001, and T-016 induced regenerative/adaptive changes and microsteatosis accompanied by increased 
AST and ALT levels, respectively; T-011 provoked focal hepatocellular necrosis and acute inflammation (see top 
left inserts in Fig. 5d–f), which was reflected in increased levels of both ALT and AST. Nevertheless, compared to 
metronidazole, the three compounds were significantly less hepatotoxic (Fig. 6).
Discussion
E. histolytica is an enteric protozoan that causes human amoebiasis, which is considered the fourth cause of para-
sitic diseases23,24. Metronidazole (a nitroimidazole derivative) is often the selected drug to treat amoebiasis, how-
ever, this drug is mutagenic, carcinogenic and genotoxic25 and has many other undesirable side effects, amongst 
others neurotoxicity26,27. Likewise, the appearance of strains of E. histolytica resistant to conventional drugs has 
been reported28.
Given the aforementioned, the search for new anti-amoebic agents continues to be a global trend, for which 
different approaches have been taken, from the synthesis of new compounds29,30 to the systematic study of natu-
ral products14,31. Anti-amoebic activity is traditionally tested in vitro using axenic strains of E. histolytica32–34; in 
addition, and taking into account the necessary breakdown of intercellular structures for infection, cell lines such 
as Caco-2, T84 and MDCK have been used for interaction studies during amoebiasis35. In silico analysis are also 
used36–38.
Although the use of in vitro and in silico assays allow the screening of a large number of molecules in record 
time, the scope and limits of the results obtained have been questioned since these models reflect the in vivo situ-
ation only partially, and do not allow studies of drug-parasite-host interactions39, which is of great importance for 
the study of adherent parasites such as E. histolytica. Animal models also have been used for the study of amoe-
biasis, however they have the disadvantage that is not possible to induce both intestinal and hepatic lesions in the 
same animal host13. Since E. histolytica only infects humans and non-human primates, results obtained in in vivo 
studies with laboratory animals cannot always be translated directly to humans. The practical application of using 
in vivo tests for the investigation of new compounds or molecules with anti-amoebic activity is limited by both, 
the large number of animals that would be needed, and by the large amount of compounds required.
Because of the above mentioned we implemented the use of precision-cut intestinal and hepatic tissue slices 
as an alternative model to study anti-amoebic activity of compounds with potential effect against E. histolytica 
using the organs from the same animal. Precision-cut intestinal and hepatic tissue slices are considered an ex vivo 
3D model with intermediate characteristics between in vitro and in vivo systems40, they are also considered as 
mini-organs with metabolic capacity to transport and metabolize chemical drugs17,41,42.
In the present work, we describe in detail the implementation of the ex vivo infection model of hamster intes-
tine slices with E. histolytica trophozoites, since previously we reported the usefulness of hamster liver slices as 
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an infection model with the same parasite. Results using liver slices infected with amoebae in the currently study 
are identical to those obtained in our previous work18,19. We also validated intestinal and hepatic slices as exper-
imental infection models using compounds with known anti-amoebic activity. In the current study, intestinal 
slices were cultured up to 9 h in the presence of the amoebae (12 h of incubation in total). Other investigators have 
reported maintenance of intestinal slice viability during similar culture periods. For example, de Kanter et al.43, 
and van de Kerkhof et al.44 reported maintenance of viability and metabolic activity up to 3 h of culturing. Two 
hours of incubation was used to analyze the interaction of xenobiotic agents with transporting proteins in the 
intestine45. Other authors have shown that small and large intestine slices remain viable for 8 and 24 h respectively 
when the intracellular ATP content was evaluated, while after 24 h most of the phase I and II enzymes implicated 
in metabolic transformation show significant changes depending on the origin of the tissue46. The incubation 
time over which tissue slices remain viable depends on the tissue, where 96 and 24 h are suitable for liver slices and 
intestinal slices respectively47. In general terms, we were able to observe the typical lesions of the amoebic disease 
during the ex vivo infection of both PCLS and PCIS. Incubation during longer times with the virulent strain of E. 
histolytica caused massive destruction of both tissues due to the amoebae infection.
To ensure that the amoebicides T-001, T-011 and T-016 are selectively toxic towards the amoebae, we analyzed 
their cytotoxic effect in vitro on Vero cells, a well-characterized kidney derived cell line that is not tumorigenic 
below particular passage numbers48 and therefore, it is frequently used as a normal cell line to determinate tox-
icity during preliminary screens of several compounds with biological activity15,49. Since Vero cells are useful to 
select those compounds that can be further tested or characterized in more complex systems, we found that the 
concentrations used in our tests were not harmful in vitro (IC50 > 100 µM). One of the compounds, T-011, showed 
in vitro cytotoxicity at a concentration of 5.86 µM, however to decrease the cytotoxic effect, the concentration of 
this compound may be reduced since the IC50 value vs E. histolytica is 0.35 µM.
Figure 1. Preparation of hamster tissue slices. To obtain intestinal slices (upper panel), all the steps were 
performed under aseptic conditions, in no more than 1 h. (a) After dissection, the intestinal content was washed 
with cold KB buffer and the colon was divided in 3 cm segments; clean fragments were placed into ice-cold KB 
buffer. (b) The adhering fatty tissue was carefully removed. (c) One side of the intestinal fragments were tied 
with surgical thread and filled with 3% low melting point agarose at 37 °C. (d) Agarose infiltrated fragments 
filled with agarose were transferred into ice-cold KB buffer to permit the agarose solidification. (e) The intestinal 
segments were collocated in the tissue embedding unit of the Krumdieck tissue slicer and a pin was placed in 
the solid agarose to help the filling with 2% low melting point agarose at 37 °C of the mold in order to form 
cylinders containing the colon segments. (f) Colon tissue slices (300–400 µm thickness) were prepared using the 
Krumdieck tissue slicer and were collected in ice-cold KB buffer and incubated in culture medium at 37 °C. The 
process to obtain liver slices (lower panel) is simpler than intestinal slices; the process was also performed under 
sterile conditions, and in the shortest possible time. (g) After the liver was removed, it was placed into ice-cold 
KB buffer and the hepatic lobes were separated with a scalpel. (h) The hepatic lobes were cored into 5 mm 
diameter cylinders. (i) The cores were then placed in oxygenated KB buffer (4 °C, 95:5 O2: CO2). (j) Liver tissue 
slices with 250–300 µm thickness were prepared using the Krumdieck tissue slicer and were gently placed and 
incubated onto 24-well microplates with culture medium at 37 °C.
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One of the main challenges in the ex vivo intestinal tissue culture is the maintenance of viability50. However, in 
the present study the intestine and liver slices were cultured for 12 and 24 h respectively for the infection assays, 
maintaining metabolic viability as evaluated by the Alamar blue assay (data no shown) and preserving the mor-
phological structure without alterations. Our results are similar to those reported by van de Kerkhof et al.51, and 
by Bansal et al.20, who have maintained ex vivo tissue cultures during 3 h and 7 h, respectively.
The first pathologic signs that we observed during the experimental infection of the intestinal tissue slices were 
ulceration of the mucosa and acute inflammation, whilst liver slices showed dilatation of the sinusoidal spaces, 
and micro abscesses. Numerous viable amoebae were seen in both infected tissues. Even though tissue slices have 
a lack of bloodstream, the observed inflammatory process could be related to a specific pattern of endogenous 
chemoattractants and inflammatory chemokines produced by immune and cells present in the intestine tissue 
when tissues were collected, since it is known that the gastrointestinal mucosa is the largest reservoir of mac-
rophages in the body20,52. In the same way, Bansal et al.20 reported the presence of monocytes and T-lymphocytes 
within the lamina propria of colonic explants, as well as the recruitment and migration of neutrophils and other 
resident immune cells to the site of infection which contributed to the immune response in intestine explants. 
This suggests that intestinal tissue slices remain immunologically actives.
The fact of observing histopathological changes from 3 h of interaction between E. histolytica with the intestinal 
and hepatic tissue slices suggests that the infection and invasive process starts before this time. In addition, intrac-
ryptic abscesses were observed at 9 h of incubation. These changes are similar to those reported by Houpt et al.53  
in C3H/Hej mice infected with E. histolytica; they also observed viable amoebae in areas of epithelial ulceration 
and severe inflammation as reflected by the presence of plasma cells, neutrophils, and mast cells. Likewise, E. his-
tolytica trophozoites degraded the intestinal epithelium and penetrated the mucosa of human intestine explants 
after 7 h of incubation54,55. In addition, Bansal et al.20 reported that trophozoites reach the epithelial surface and 
remove the mucosa, detaching the enterocytes and migrating along the crypts. These results are similar to those 
obtained in the present work. Indeed, the same microscopic changes were described in both in vivo and ex vivo 
models since 1970 by Prathap and Gilman, and by Espinosa-Cantellano and Martínez-Palomo for human amoe-
bic ulcerative colitis56. Our results lead us to believe that the experimental model of intestinal and hepatic tissue 
slices can be a valuable tool to predict the effect of anti-amoebic compounds in the early stages of E. histolytica 
infection. Although tissue slices have been well accepted for xenobiotic toxicity and metabolism studies57,58, as 
well as models for ex vivo infection with viruses59,60, bacteria39, and parasites20,61, the present work represents the 
first report of the in situ effect of compounds with anti-amoebic properties on the progression of infection by 
Figure 2. Macroscopic and microscopic view of intestinal slices. (a) Panoramic view of freshly obtained 
intestinal slices showing the typical aspect of intestine fragments cut transversally and, in the insert, a close view 
of the brush border microvilli; (b–e) Microphotographs shows colonic mucosa with well-preserved histologic 
architecture during different incubation time, 0, 3, 6 and 9 h, respectively. H&E stain (Total magnification: 
100X).
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E. histolytica in organotypic culture of both, hepatic and intestinal tissues derived from the same animal. 
Therefore, a significant reduction of biological variability into the experimental repetitions due to the biological 
responses between animals and even within the same animal is possible62.
It is currently well known that liver slices represent a mini liver model with all the different cell types in their 
original microenvironment, having metabolic activity, whereas most cell lines have not63, and therefore represent 
a more suitable ex vivo model for measuring liver damage induced by different agents64. Since hepatotoxicity is an 
adverse reaction that may be induced by novel compounds being studied, models capable of predicting hepatic 
toxicity are necessary. Given that ALT and AST enzymes are considered as sensitive biochemical indicators of 
cellular injury and metabolic disturbances65 we determined both enzyme levels on the hepatic slices treated with 
the synthetic compounds and metronidazole. Increased levels of ALT and AST enzymes indicate a toxicological 
effect of the tested compounds66, therefore, their increase in tissues treated with T-011 confirm the cytotoxicity 
found on Vero cells (IC50 = 5.86 µM) and their lower selectivity (SI 16.74) compared to tissues treated with T-001 
and T-016, which are not toxic to Vero cells and exhibited higher selectivity (SI > 65). Also, T-011 Induced more 
pathological changes at histologic level. T-001 and T-016 induced less inflammation and necrosis, and raised one 
of the two hepatic enzymes. Nevertheless, compared to metronidazole, the three compounds were significantly 
less toxic in tissue cultures at the used concentrations.
Although compounds T-001 and T-016 did not exert cytotoxic effects on Vero cell (IC50 > 100), it is well 
known that in vitro tests using cell monolayers are limited models because they are very different from the start, 
since generally they are dedifferentiated and lack, amongst others of transport systems and metabolic enzymes67 
as well as of the ability to maintain histotypic and phenotypic characteristics overtime68. The latter may explain 
Figure 3. Experimental infection of intestinal slices cultured ex vivo. These microphotographs show the 
infection of the colonic mucosa with Entamoeba histolytica trophozoites in slices that were cultured for 3 h 
(a,b), 6 h (c,d), and 9 h (e,f). The most remarkable morphologic change is the ulceration of the mucosa as a 
consequence of the infection process; morphologically well conserved amoebae (arrows) are in close contact 
with epithelial cells (*) and are able to induce a severe acute inflammatory process composed mainly by 
neutrophils and eosinophils (dotted area in Fig. d). Figures b, d, and f correspond to microscopic magnifications 
of figures a, c, and e, respectively. H&E stain (Total magnification: 100X, 400X).
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the discrepancies observed between in vitro studies and 3D models, as in the present work where the active 
compounds showed a modest cytotoxic effect on the intestine and liver slices at much lower concentrations than 
where cytotoxicity was seen in the cell line. Similarly, van de Kerkhof et al.51 showed a high metabolic rate in 
intestinal tissue slices that can be up to 3 times higher than that estimated in hepatocytes in liver tissue slices.
As it has been said, 3D cultures have great potential to fill the gap between cell-based research and animal 
models to study host-pathogen interactions, as well as contribute to the development of new treatments69. The 
usefulness of organotypic cultures to understand the pathogenesis of different diseases, as well as their potential as 
preclinical models, has led to subsequent applications of similar models that had already been validated20,55. The 
use of these ex vivo models responds to the increasingly clear need to use physiologically more relevant systems 
and perform better in vitro-in vivo extrapolations (IVIVE)68 for many different diseases, like amoebiasis.
In conclusion, our study demonstrate that precision-cut hamster intestinal and liver slices infected with E. 
histolytica trophozoites represent a 3D model that allows to simultaneously evaluate both anti-amoebic potential 
of new compounds, and their possible toxicity. Using this model we showed that T-001, T-011, and T-016, novel 
synthetic compounds reported as amoebicidal are equally effective against E. histolytica as the golden standard 
metronidazole currently used for treatment of the disease, without compromising tissue viability to great extent.
Materials and Methods
Animals. The study protocol was approved (Approval: R-2012-785-020) by the National Committee for 
Scientific Research from the Instituto Mexicano del Seguro Socia (IMSS). Two month old male Syrian golden 
hamsters (Mesocricetus auratus) obtained from the animal facility of the Northeast Biomedical Research Center 
(IMSS), Monterrey, México were used. The animals were kept in polycarbonate cages, with free access to food 
and water. Animal handling was in accordance with the international principles on ethical management and care, 
and according to the Official Mexican Norm NOM 062-ZOO-1999: Technical Specifications for the Production, 
Care and Use of Laboratory Animals, the guidelines from the Institutional Biosecurity Committee (IMSS), and 
the Manual of Procedures and Recommendations for Animal Research, 2012. All methods were performed in 
accordance with these approved guidelines.
E. histolytica culture. Virulent trophozoites from E. histolytica strain HM1-IMSS were cultured and main-
tained axenically in TYI-S-33 (Trypticase-Yeast extract-Iron-Serum) medium supplemented with 10% bovine 
serum, penicillin-streptomycin, and Diamond® vitamins. The subculture and the bioassays were performed when 
the amoebae were in the logarithmic phase of growth.
Figure 4. Amoebicide effect of T-001, T-011 and T-016 on hamster intestinal slices. Microphotographs show 
intestinal tissue cultured for 9 h. (a) Negative control, intestinal mucosa without morphological alterations; 
(b) infection control showing the presence of conserved amoebae (*) at the intraluminal level (insert), as 
well as severe acute inflammation, ulceration of the intestinal mucosa and intracryptic abscesses; (c) in the 
pharmacological control (metronidazole) dirty background is observed due to the presence of cellular debris 
coming from inflammatory cells, fragments are also identified and alteration of amoebic structures (arrows) in 
comparison with trophozoites showing erythrophagy (*). In the slices incubated in the presence of (d) T-001, 
(e) T-011, and (f) T-016 damage to amoebae (arrows) was also observed, which is characterized by amoeba 
fragmentation, although slightly less than pharmacological control. Compound T-011 at the used concentration 
showed greater amoebicidal tendency than T-001 and T-016. In non-infected intestinal slices incubated only 
with the synthetic compounds, morphological changes suggestive of toxicity were not observed (data not 
shown). H&E stain (Total magnification: 100X and 400X).
8Scientific RepoRts |          (2019) 9:8396  | https://doi.org/10.1038/s41598-019-44899-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
Amoebicidal compounds. The synthetic compounds T-001, T-011, and T-016 were synthetized and iden-
tified according to the methods reported by Duque-Montaño et al.11.
Cytotoxicity of the compounds T-001, T-011, and T-016 on Vero cells. As a preliminary step to the 
analysis of the anti-amoebic activity of the synthetic compounds on the intestinal and hepatic tissue slices, their 
possible cytotoxicity on Vero (ATTC®CCL-81™) cell cultures was evaluated. This cell line is used worldwide to 
assess the in vitro cytotoxic effect and/or selectivity index of different compounds70–74. Additionally Vero cells 
are endorsed by ISO experts to be suitable to test cytotoxicity of certain compounds and materials of medical 
devices75.The cell line was cultured in Eagle’s Minimum Essential Medium supplemented with 10% fetal bovine 
serum and 1% (v/v) of a mixture of 100 IU/mL penicillin/50 µg/mL streptomycin. For the cytotoxicity analysis, 
confluent logarithmic growth phase cultures were used after 10,000 cells/100 μL were seeded in each of the wells of 
Figure 5. Amoebicide effect of T-001, T-011, and T-016 on ex vivo cultures of hamster hepatic slices. Non-
infected (control) liver slices (a) shows the typical histological structure of hepatic tissue: hepatocytes (h), 
sinusoidal space (s) and central vein (cv). (b) Liver slices infected with trophozoites shows numerous amoebae 
(arrows) and a pronounced dilatation of the sinusoidal spaces (*). The amoebicide effect of metronidazole 
(c) is evident by a diminution in the number of amoebae per microscopic field; most of them were dead and 
in process of disintegration (dotted line). (d) T-001, (e) T-011, and (f) T-016, also induced a decrease in the 
number of amoebae and provoked similar morphological damage to metronidazole (arrows), and in addition, 
induced inflammatory reactions (dotted area in the insert of Fig. e). Non-infected slices were also incubated 
in the presence of the synthetic compounds (top left figure inserts in d–f), while T-001 and T-016 induced 
regenerative changes and cytoplasmic vacuolization, T-011 induced focal hepatocellular necrosis and acute 
inflammation (dotted line in the insert). H&E stain (Total magnification: 400X).
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a 96-well plate. The microplate was incubated overnight and then the compounds were added in a concentration 
range of 0.1 to 100 μM and incubated for an additional 48 h at 37 °C, in a humid atmosphere and 5% CO2. The 
viability of the cells incubated in the presence of T-001, T-011, and T-016 was determined by the WST-1 assay, 
which is directly proportional to the number of viable cells76. The assay was carried out in duplicate.
Precision-cut hamster intestine slices preparation. The entire process was performed at 4 °C under 
sterile conditions, in the shortest time of surgical manipulation in order to minimize the autolysis of the intestinal 
tissue due to ischemia. Briefly: the hamsters received an intraperitoneal injection of sodium pentobarbital (64 mg/ 
100 g of weight). Once in deep anesthesia, the colonic portion of the large intestine was carefully removed and 
divided into fragments of three centimeters long. These fragments were placed into Krebs-Henseleit buffer (KB 
buffer) at 4 °C, and were washed with the same buffer to remove the intestinal content, and then the superficial 
adipose tissue was carefully removed. Afterwards, the intestinal fragments were tied using surgical thread at one 
end, while on the opposite side was filled with low melting point agarose at 37 °C and placed in KB buffer at 4 °C 
for the agarose solidification. The fragments of intestine filled with agarose were placed in the tissue embedding 
unit of the Krumdieck tissue slicer in order to prepare regular agarose cylinders. These cylinders were placed in 
the sample holder of the Krumdieck tissue slicer, and intestinal tissue slices with thickness of 300–400 μm were 
prepared, always under constant recirculation of KB buffer at 4 °C gassed with carbogen (95% O2/5% CO2). The 
slices were collected in KB buffer at 4 °C to remove the external ring of agarose with aid of a spatula. Figure 1 
shows general aspects of the process to prepare both intestinal and hepatic slices.
Culture and ex vivo infection of intestinal slices. Once the intestine slices were obtained, those with the 
best macroscopic appearance were selected. Subsequently, two slices were placed per well of a 24-well microplate, 
each well containing 1 mL of DMEM/F12 medium supplemented with 10% fetal bovine serum, 25 mM glucose 
and 10 mg/L gentamicin and subsequently pre-incubated for 1 h at 37 °C in a cell culture incubator to stabilize 
the tissue. The intestinal slices were infected with 200,000 virulent trophozoites of E. histolytica suspended in 
2 mL of 1:1 mix of TYI-S-33 medium and complete DMEM/F12 medium. As control, non-infected slices were 
used. The microplate was incubated resting during 2 h at 37 °C to allow the adherence of the amoebae with the 
tissue. After this time, the slices were transferred under sterile conditions to another 24-well microplate contain-
ing 1 mL of the 1:1 mix of TYI-S-33 and DMEM/F12 media and two washes were performed with KB buffer, to 
eliminate amoebae that were not attached to the intestinal tissue; infected slices were incubated in 2 mL of the 
same medium at 37 °C and 95% O2/5% CO2 under agitation at 30 rpm. Samples were taken at 0, 3, 6, and 9 h for 
subsequent analysis.
Preparation, culture and infection of hamster liver slices with E. histolytica. The obtaining and ex vivo 
culture of hamster liver slices, as well as their subsequent experimental infection, was carried out according to the 
protocols previously described by our research group18,19.
Anti-amoebic activity of T-001, T-011, and T-016 on precision-cut hamster intestinal and liver 
slices. After the ex vivo infection of the intestine and liver slices with E. histolytica trophozoites, slices from 
both tissues were pre-incubated separately in microplates with 1 mL of complete culture medium for 3 h and then, 
1.41 μg/mL T-001, 0.35 μg/mL T-011, and 1.47 μg/mL T-016 were added in triplicate wells. These concentrations 
correspond to the IC50 of each compound previously reported in vitro by Duque-Montaño et al.11. Metronidazole 
(IC50 = 4.5 μg/mL) was used as the reference amoebicide drug, whereas 0.3% DMSO and culture medium were 
used as solvent control and negative control, respectively. The infected and control slices, as well as those treated 
with the synthetic compounds, were incubated at 37 °C with 95% O2/5% CO2 and agitation at 30 rpm for 3, 6, and 
Figure 6. Tissue toxicity of T-001, T-011, and T-016 on precision-cut hamster liver slices. Hepatic ALT and 
AST levels were measured after 24 h incubation of tissue liver slices in the presence of the three synthetic 
compounds, MTZ and control negative (culture medium). Each line represents the group mean ± S.D. (n = 3). 
Asterisk (*) indicates significant difference (p < 0.05) compared with control (−) and, hash (#) indicates 
significant difference (p < 0.05) compared with positive control (+) MTZ in each sample.
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12 h for intestinal tissue, and 3, 6, 12 and 24 h for liver tissue. At the end of each incubation, slices were fixed in 
10% neutral formalin for histopathological analysis. Three independent experiments were performed.
Hepatotoxicity of T-001, T-011, and T-016. Cell-specific biomarkers analyzed included AST (aspartate 
aminotransferase) and ALT (alanine aminotransferase) for liver parenchyma. ALT and AST are enzymes consid-
ered as sensitive biochemical indicators used to evaluate cellular injury, metabolic disturbances, and enzyme inac-
tivation or induction by exogenous chemicals; and their presence in the liver effluent is a reflection of hepatocyte 
lysis as consequence of chronic inflammation and other sources of liver injury65,77. To evaluate the possible tissue 
toxicity of the synthetic compounds, liver slices were incubated for 24 h in the presence of the same concentra-
tions used in the infection assays. After incubation, hepatic enzymes ALT and AST were measured as described 
by Behrsing et al.78. Briefly: liver slices were removed from the microplate wells and gently rinsed with PBS, 
afterwards, each slice was transferred into 2.0 ml Potter-Elvehjem tissue grinder containing 0.5 ml PBS + 0.5% 
Triton X-100 on ice to homogenize the slices. The resulting lysates were centrifuged at 9000 g for 5 min to remove 
particulate matter. The resulting supernatants were analyzed on a Hitachi 911 clinical analyzer. Three independ-
ent experiments were performed.
Histopathological analysis. After each incubation time the slices were washed with PBS at 37 °C and fixed 
in 10% buffered formalin for 24 h at room temperature. After a dehydration and clarification process, paraffin 
blocks were prepared for each treatment and sections of 5 μm thickness were prepared using a conventional 
microtome. The sections were stained with hematoxylin and eosin (H&E) and observed in a light field micro-
scope. Histopathological criteria such as integrity of the nucleus, cytoplasm, cell membranes, as well as the degree 
of cellular damage and the interactions between trophozoites and intestinal or hepatic tissue were used, in order 
to evaluate the morphological characteristics of the tissue. The effect induced by treatment with the synthetic 
compounds and metronidazole on these morphological parameters was determined in both infected and control 
slices.
Statistical analysis. The data from control and treatment groups were analyzed using t-test analysis. Values 
were considered significantly different if p < 0.05.The SPSS software version 21 was used.
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